Market Insights Health OTC Pharmaceuticals

Digestives & Intestinal Remedies - Worldwide

Worldwide

The Digestives & Intestinal Remedies market market worldwide is projected to generate a revenue of €17.73bn in 2024.
It is anticipated that the market will experience an annual growth rate of 3.21% (CAGR 2024-2029).
In terms of global comparison, in China leads the market with a revenue of €4,087.00m in 2024.
When considering the total population, the per person revenue in 2024 is €2.29.
Despite the availability of various alternatives, the demand for Digestives & Intestinal Remedies remains high in countries worldwide due to the increasing prevalence of digestive disorders.

Key regions: Canada, United States, Australia, Brazil, Japan

Marché

Région

Comparaison de régions

Monnaie

Analyst Opinion

The Digestives & Intestinal Remedies market is experiencing significant growth worldwide.

Customer preferences: Customers are increasingly seeking natural and organic remedies for digestive issues, leading to a rise in demand for herbal and plant-based products. This preference for natural ingredients is driven by a growing awareness of the potential side effects of traditional pharmaceuticals and a desire for more holistic approaches to healthcare. Additionally, consumers are becoming more proactive in managing their digestive health, leading to an increased demand for over-the-counter remedies that can be easily accessed and self-administered.

Trends in the market: One of the key trends in the Digestives & Intestinal Remedies market is the growing popularity of probiotics. Probiotics are live bacteria and yeasts that are beneficial for digestive health. They are commonly found in yogurt, fermented foods, and dietary supplements. The demand for probiotics is driven by the increasing understanding of the gut microbiome and its impact on overall health. Consumers are turning to probiotics to improve digestion, boost immunity, and alleviate symptoms of digestive disorders such as irritable bowel syndrome.Another trend in the market is the rise of functional foods and beverages that promote digestive health. These products are fortified with ingredients such as fiber, prebiotics, and enzymes that aid digestion and promote gut health. This trend is driven by the growing interest in preventive healthcare and the desire for convenient and easy-to-consume products that offer health benefits beyond basic nutrition.

Local special circumstances: In developed countries, such as the United States and European countries, the Digestives & Intestinal Remedies market is driven by an aging population and the high prevalence of digestive disorders. As people age, they are more prone to digestive issues such as constipation, acid reflux, and gastrointestinal disorders. This demographic trend is fueling the demand for products that can alleviate these symptoms and improve overall digestive health.In emerging markets, such as China and India, the Digestives & Intestinal Remedies market is driven by changing lifestyles and dietary habits. Rapid urbanization and Westernization of diets have led to an increase in digestive disorders such as indigestion, bloating, and food intolerances. The growing middle class in these countries is willing to spend more on healthcare and wellness products, driving the demand for Digestives & Intestinal Remedies.

Underlying macroeconomic factors: The global Digestives & Intestinal Remedies market is also influenced by macroeconomic factors such as healthcare expenditure, disposable income, and healthcare infrastructure. As healthcare spending increases, consumers have more access to healthcare services and are more likely to seek remedies for digestive issues. Similarly, higher disposable income allows consumers to afford premium products and services in the Digestives & Intestinal Remedies market. Lastly, a well-developed healthcare infrastructure enables better diagnosis and treatment of digestive disorders, driving the demand for related remedies.In conclusion, the Digestives & Intestinal Remedies market is experiencing growth worldwide due to customer preferences for natural and organic remedies, trends such as the popularity of probiotics and functional foods, local special circumstances such as an aging population and changing lifestyles, and underlying macroeconomic factors such as healthcare expenditure and disposable income.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.